Stay updated with breaking news from Tsutomu takeuchi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ozoralizumab demonstrates a long half-life and favorable pharmacokinetics, as well as sustained efficacy, over 52 weeks in patients with rheumatoid arthritis, according to data published in Arthritis Research & Therapy. ....
Investegate announcements from Galapagos NV, Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022 ....